Brief: QT Imaging Granted Renewal Of NIH Sponsored Study For Early Identification Of Response Of Breast Cancer Patients To Neoadjuvant Chemotherapy
29/10/2024 12:34
Oct 29 (Reuters) - QT Imaging Holdings Inc QTI.O :
* QT IMAGING GRANTED RENEWAL OF NIH SPONSORED STUDY FOR
EARLY
IDENTIFICATION OF RESPONSE OF BREAST CANCER PATIENTS TO
NEOADJUVANT CHEMOTHERAPY
Source text: ID:nBw2lXB9a
Further company coverage: QTI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on QT Imaging Holdings
See all newsBrief: Qt Imaging’S Breast Acoustic Ct Scanner Now Available Through National Group Purchasing Agreement With Premier
QT Imaging Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
QT Imaging Q2 revenue more than doubles
QT Imaging Holdings Inc expected to post a loss of 22 cents a share - Earnings Preview
QT Imaging Holdings Inc expected to post a loss of 22 cents a share - Earnings Preview